Roche Products Pty Ltd
Regulatory activities for this sponsor.
Loading...
Sponsor content
211 result(s) found, displaying 81 to 90
-
Roche Products Pty Ltd - Medicine administration kit, oral ancelled under Section 41GL(d) of the Act
Cancellation by sponsorRequested by Roche Products Pty Ltd -
Cancellation by sponsorRequested by Roche Products Pty Ltd
-
Australian Public Assessment Report (AusPAR)Australian Public Assessment Report for Entrectinib
-
Prescription medicine decision summaryTGA decision: ENSPRYNG (satralizumab) is approved to treat adults with neuromyelitis optica spectrum disorders who have an AQP4-IgG.
-
Prescription medicine registrationActive ingredients: satralizumab.
-
Cancellation by sponsorRequested by Roche Products Pty Ltd
-
Cancellation by sponsorRequested by Roche Products Pty Ltd
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for Roche Products Pty Ltd - Medicine administration kit, percutaneous, non-medicated, single-use.
-
Prescription medicine registrationActive ingredients: atezolizumab.
-
Prescription medicine registrationActive ingredients: entrectinib.